Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension
Clinical trial NCT05437224 · COMPLETED
Trial details
- NCT number
- NCT05437224
- Sponsor
- RenJi Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2022-01-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.